Severe COVID-19 and breakthrough infections in vaccinated schizophrenia patients: A matched controlled cohort study

INTRODUCTION: Schizophrenia patients are at an increased risk for severe SARS-CoV-2 illness. Recent studies indicate that vaccines reduce morbidity gaps between schizophrenia patients and the general population; nonetheless, the ongoing emergence of COVID-19 variants and the increased frequency of b...

Descripción completa

Detalles Bibliográficos
Autor principal: Tzur Bitan, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596184/
http://dx.doi.org/10.1192/j.eurpsy.2023.326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596184/
http://dx.doi.org/10.1192/j.eurpsy.2023.326

Ejemplares similares